STUDY OF AWARENESS AND UTILITY OF CARTRIDGE BASED NUCLEIC ACID AMPLIFICATION TEST (CBNAAT) AMONGST DOCTORS

Dr. Swapnil Sanjay Kakad, Dr. Gauri Godbole, Dr. Suhas Kulkarni, Dr. Tejas Deshpande

Abstract


Introduction: CBNAAT is one of the most useful investigations in detecting tuberculosis and drug resistance. It is now included in new RNTCP guidelines. Majority of patients with tuberculosis receive care from a primary care physician such as general practitioners and the rest obtain treatment from specialists including respiratory physicians. This study aims to explore the awareness and utility of CBNAAT amongst general practitioners and specialists other than respiratory physicians.

Aim:  To obtain data regarding awareness and utility of the CBNAAT amongst the doctors.

Methodology: A survey was carried out amongst the general practitioners including AYUSH doctors and specialists other than Respiratory physicians in the vicinity of our hospital regarding the awareness and utility of CBNAAT.

Results: The awareness amongst surveyed population showed partial awareness regarding the CBNAAT and its utility is thus inadequate.

Conclusion: It was concluded that many aspects of CBNAAT is not known to general practitioners.


Keywords


CBNAAT, Tuberculosis, awareness, utility.

Full Text:

PDF

References


Helb D, et al. Rapid detection of mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol. 2010;48:229–237. doi: 10.1128/JCM.01463-09

Corbett EL, Watt CJ, Walker N et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003; 163 (9): 1009-21.

Swaminathan S, Ramachandran R, Baskaran G et al. Risk of development of tuberculosis in HIV-infected patients. Int J Tuberc Lung Dis 2000; 4 (9): 839-44.

Matee M, Mtei L, Lounasvaara T et al. Sputum microscopy for the diagnosis of HIV-associated pulmonary tuberculosis in Tanzania.BMC Public Health 2008; 8: 68.

World Health Organization (2014) Xpert MTB/RIF implementation manual: technical and operational ‘how-to’; practical considerations. ISBN: 978 92 4 150670 0 (NLM classi cation: WF 310) World Health Organization

Kasat S, Biradar M, Deshmukh A, Jadhav S, Deshmukh H. Effectiveness of CBNAAT in the diagnosis of extrapulmonary tuberculosis. Int J Res Med Sci 2018;6:3925-8.

Chaudhuri AD. Recent changes in technical and operational guidelines for tuberculosis control programme in India - 2016: A paradigm shift in tuberculosis control. J Assoc Chest Physicians 2017;5:1-9.

Chaudhary A, Barve K, Desai U, Joshi J. Utility of GeneXpert in diagnosis of multidrug-resistant extrapulmonary tuberculosis. Inter J Recent Surg Med Sci. 2017;3(2):85-7.

. Dewan R, Anuradha S, Khanna A, et al. Role of cartridge-based nucleic acid amplification test (CBNAAT) for early diagnosis of pulmonary tuberculosis in HIV. JIACM. 2015;16(2):114–117

Sharma SK, Mohan A. Extrapulmonary tuberculosis. Ind J Med Res. 2004;120(4):31653.

WHO Policy statement: automated real-time nucleic acid amplification technology for rapid and simultaneousdetection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system 2011. Available at: http://www.who.int/tb/laboratory/en/

Experience with implementation of Xpert MTB/RIF in India;Report by Dr KS Sachdeva, Addl DDG (TB), Govt of india. Available at www.stoptb.org. Accessed on 25/12/2014.

World Health Organization (2014) Xpert MTB/RIF implementation manual: technical and operational ‘how-to’; practical considerations. ISBN: 978 92 4 150670 0 (NLM classi cation: WF 310) World Health Organization


Refbacks

  • There are currently no refbacks.